See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2013_Biospecifics_Technologies_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000875622, Biospecifics Technologies CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 13,875,801 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 280,322 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 4,234,141 |
| 4 | LiabilitiesCurrent | 724,528 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,774,828 |
| 9 | ResearchAndDevelopmentExpense | 1,249,755 |
| 10 | remainder_Expenses | 2,174,054 |
| 11 | remainder_Revenues | 11,145,078 |
| 12 | remainder_NetIncome | 34,634 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 18,390,264 |
| 1 | Liabilities | 724,528 |
| 2 | Expenses | 8,198,637 |
| 3 | Revenues | 11,145,078 |
| 4 | StockholdersEquity | 17,665,736 |
| 5 | NetIncome | 2,981,075 |
| 6 | ComprehensiveNetIncome | 2,981,075 |
| 7 | BaseVar | 19,246,570 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.34 |
| 9 | EconomicCapitalRatio | 4.65 |